Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development
Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely lucrative weight-loss drug market, said on Tuesday, April 14, it is partnering with OpenAI to deploy artificial intelligence across its business, from drug discovery to manufacturing and commercial operations. The maker of Wegovy and Ozempic said the partnership would use OpenAI’s technology … Read more
